This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
BETOPTIC 0,5 POUR CENT, collyre — Description, Dosage, Side Effects | PillsCard
OTC
BETOPTIC 0,5 POUR CENT, collyre
INN: BÉTAXOLOL
Data updated: 2026-04-11
Available in:
🇩🇪🇬🇧🇫🇷🇹🇷
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
IMMEDICA PHARMA (SUEDE)
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
(FR)
Source
BDPM_FR
AU:C
C07AB05(WHO)S01ED02(WHO)
In general: ℞ (Prescription only)
(RS)-1-{4-[2-(cyclopropylmethoxy)ethyl]-phenoxy}-3-(isopropylamino)propan-2-ol
63659-18-7Y
2369
549
DB00195Y
2279Y
O0ZR1R6RZ2
D07526Y
CHEBI:3082Y
ChEMBL423Y
DTXSID2022674
Interactive image
O(CCc1ccc(OCC(O)CNC(C)C)cc1)CC2CC2
InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3YKey:NWIUTZDMDHAVTP-UHFFFAOYSA-NY
Betaxololis abeta blockerused in the treatment ofhypertensionandangina.
It acts as aselectiveβ1-adrenergic receptorantagonist.
The drug was patented in 1975 and approved for medical use in 1983.